Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaofan Hu

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Translational Pediatrics|July 8, 2022
Suppressing the activity of <i>CXCR4</i> down-regulates the expression of renal fibrosis related genes in primary glomerular cellsShaofan Hu, Hong Liu, Qun Li, et al.
International Journal of Biological Macromolecules|October 22, 2023
STC2 is a potential biomarker of hepatocellular carcinoma with its expression being upregulated in Nrf1α-deficient cells, but downregulated in Nrf2-deficient cellsQiqi Bu, Yangxu Deng, Qing Wang, et al.
Frontiers in Immunology|January 5, 2026
The metabolism-immune axis in colorectal cancer: remodeling the tumor microenvironment through metabolite signalingShaofan Hu, Hui Heng, Fang Yang, et al.
Bioorganic Chemistry|February 20, 2024
Genetic loss of Nrf1 and Nrf2 leads to distinct metabolism reprogramming of HepG2 cells by opposing regulation of the PI3K-AKT-mTOR signalling pathwayRongzhen Deng, Yuping Zhu, Keli Liu, et al.
International Journal of Molecular Sciences|September 23, 2022
Different Inhibition of Nrf2 by Two Keap1 Isoforms α and β to Shape Malignant Behaviour of Human Hepatocellular CarcinomaFeilong Chen, Mei Xiao, Jing Feng, et al.
Antioxidants (Basel, Switzerland)|August 26, 2022
Distinct Roles of Nrf1 and Nrf2 in Monitoring the Reductive Stress Response to Dithiothreitol (DTT)Reziyamu Wufuer, Zhuo Fan, Jianxin Yuan, et al.
Plos One|November 27, 2023
Nrf1 is not a direct target gene of SREBP1, albeit both are integrated into the rapamycin-responsive regulatory network in human hepatoma cellsKeli Liu, Shaofan Hu, Lu Qiu, et al.
Antioxidants (Basel, Switzerland)|December 22, 2019
Unification of Opposites between Two Antioxidant Transcription Factors Nrf1 and Nrf2 in Mediating Distinct Cellular Responses to the Endoplasmic Reticulum Stressor TunicamycinYu-Ping Zhu, Ze Zheng, Shaofan Hu, et al.
Cancers|December 20, 2018
Oncogenic Activation of Nrf2, Though as a Master Antioxidant Transcription Factor, Liberated by Specific Knockout of the Full-Length Nrf1α that Acts as a Dominant Tumor RepressorLu Qiu, Meng Wang, Shaofan Hu, et al.
Free Radical Biology & Medicine|January 26, 2024
Distinct mechanisms by which Nrf1 and Nrf2 as drug targets contribute to the anticancer efficacy of cisplatin on hepatoma cellsReziyamu Wufuer, Keli Liu, Jing Feng, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Translational Pediatrics|July 8, 2022
Suppressing the activity of <i>CXCR4</i> down-regulates the expression of renal fibrosis related genes in primary glomerular cellsShaofan Hu, Hong Liu, Qun Li, et al.
International Journal of Biological Macromolecules|October 22, 2023
STC2 is a potential biomarker of hepatocellular carcinoma with its expression being upregulated in Nrf1α-deficient cells, but downregulated in Nrf2-deficient cellsQiqi Bu, Yangxu Deng, Qing Wang, et al.
Frontiers in Immunology|January 5, 2026
The metabolism-immune axis in colorectal cancer: remodeling the tumor microenvironment through metabolite signalingShaofan Hu, Hui Heng, Fang Yang, et al.
Bioorganic Chemistry|February 20, 2024
Genetic loss of Nrf1 and Nrf2 leads to distinct metabolism reprogramming of HepG2 cells by opposing regulation of the PI3K-AKT-mTOR signalling pathwayRongzhen Deng, Yuping Zhu, Keli Liu, et al.
International Journal of Molecular Sciences|September 23, 2022
Different Inhibition of Nrf2 by Two Keap1 Isoforms α and β to Shape Malignant Behaviour of Human Hepatocellular CarcinomaFeilong Chen, Mei Xiao, Jing Feng, et al.
Antioxidants (Basel, Switzerland)|August 26, 2022
Distinct Roles of Nrf1 and Nrf2 in Monitoring the Reductive Stress Response to Dithiothreitol (DTT)Reziyamu Wufuer, Zhuo Fan, Jianxin Yuan, et al.
Plos One|November 27, 2023
Nrf1 is not a direct target gene of SREBP1, albeit both are integrated into the rapamycin-responsive regulatory network in human hepatoma cellsKeli Liu, Shaofan Hu, Lu Qiu, et al.
Antioxidants (Basel, Switzerland)|December 22, 2019
Unification of Opposites between Two Antioxidant Transcription Factors Nrf1 and Nrf2 in Mediating Distinct Cellular Responses to the Endoplasmic Reticulum Stressor TunicamycinYu-Ping Zhu, Ze Zheng, Shaofan Hu, et al.
Cancers|December 20, 2018
Oncogenic Activation of Nrf2, Though as a Master Antioxidant Transcription Factor, Liberated by Specific Knockout of the Full-Length Nrf1α that Acts as a Dominant Tumor RepressorLu Qiu, Meng Wang, Shaofan Hu, et al.
Free Radical Biology & Medicine|January 26, 2024
Distinct mechanisms by which Nrf1 and Nrf2 as drug targets contribute to the anticancer efficacy of cisplatin on hepatoma cellsReziyamu Wufuer, Keli Liu, Jing Feng, et al.
Pageof 4